Epigral Ltd. (NSE:EPIGRAL) — Market Cap & Net Worth
Market Cap & Net Worth: Epigral Ltd. (EPIGRAL)
Epigral Ltd. (NSE:EPIGRAL) has a market capitalization of $507.94 Million (Rs46.97 Billion) as of August 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #11951 globally and #604 in its home market, demonstrating a -5.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Epigral Ltd.'s stock price Rs1088.70 by its total outstanding shares 43141338 (43.14 Million). See how much does Epigral Ltd. reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Epigral Ltd. Market Cap History: 2023 to 2026
Epigral Ltd.'s market capitalization history from 2023 to 2026. Data shows growth from $454.29 Million to $507.94 Million (2.87% CAGR).
Index Memberships
Epigral Ltd. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.15 Trillion | 0.04% | #300 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.26 Trillion | 0.02% | #466 of 750 |
Weight: Epigral Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Epigral Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Epigral Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Epigral Ltd.'s market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.15x
Epigral Ltd.'s market cap is 0.15 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $454.29 Million | $21.69 Billion | $3.53 Billion | 0.02x | 0.13x |
| 2024 | $884.69 Million | $18.94 Billion | $1.96 Billion | 0.05x | 0.45x |
| 2025 | $569.25 Million | $25.50 Billion | $3.58 Billion | 0.02x | 0.16x |
| 2026 | $507.94 Million | $25.27 Billion | $3.32 Billion | 0.02x | 0.15x |
Competitor Companies of EPIGRAL by Market Capitalization
Companies near Epigral Ltd. in the global market cap rankings as of August 4, 2026.
Key companies related to Epigral Ltd. by market ranking:
- BASF SE (F:BASA): Ranked #596 globally with a market cap of $45.63 Billion USD ( €39.03 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #598 globally with a market cap of $45.45 Billion USD ( €38.87 Billion EUR).
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #1064 globally with a market cap of $24.99 Billion USD ( CN¥170.79 Billion CNY).
- Dow Inc (NYSE:DOW): Ranked #1170 globally with a market cap of $21.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #596 | BASF SE | F:BASA | $45.63 Billion | €12.50 |
| #598 | BASF SE | XETRA:BAS | $45.45 Billion | €50.40 |
| #1064 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $24.99 Billion | CN¥23.29 |
| #1170 | Dow Inc | NYSE:DOW | $21.83 Billion | $30.29 |
Epigral Ltd. Historical Marketcap From 2023 to 2026
Between 2023 and today, Epigral Ltd.'s market cap moved from $454.29 Million to $ 507.94 Million, with a yearly change of 2.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs507.94 Million | -10.77% |
| 2025 | Rs569.25 Million | -35.66% |
| 2024 | Rs884.69 Million | +94.74% |
| 2023 | Rs454.29 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Epigral Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $507.94 Million USD |
| MoneyControl | $507.94 Million USD |
| MarketWatch | $507.94 Million USD |
| marketcap.company | $507.94 Million USD |
| Reuters | $507.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Epigral Ltd.
Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power pl… Read more